At this price, there isn’t an attractive arbitrage opportunity to take advantage of if Amgen is going to pay $116.50 per share. But what we can look into is what this deal means for Amgen and what our tools say about the stock before the ink on this deal fully dries.
Read nowToday, I’m going to share Senior Analyst Mike Burnick’s answers, as he had two stocks he would invest in if he only had $5,000.
Read nowLandon shares an investing strategy around earnings as a third way to invest $5,000 in 2023.
Read nowWhile 2022 has been a rough year for every investor, money is made by forward-looking investors, and Joe has five cryptos he would buy with $5,000.
Read nowHis “go anywhere” approach in TradeSmith Decoder offers subscribers the ability to trade or invest in anything that shows promise. This approach helped him lead subscribers to huge gains in the wake of the COVID-19 pandemic.
Read nowBYD and Mercedes-Benz demonstrate why Tesla has no moat and the shares will fall much further.
Read nowWith this issue of Special-Situation Central, the team compiled a list of three companies that could be acquired over the next year by larger firms. All three companies offer something unique, ranging from one-of-a-kind sports content to a rich library of hit TV shows to potential treatments for a rare disease.
Read nowAs part of the outlook, I also answered the question, “If you only had $5,000 to invest for the new year, where would you put it?”
Read now
